Tianjin Medical University Cancer Institute and Hospital is the birthplace of oncology in China. It has developed into one of the largest cancer centers in China.

During the past decade, Department of Radiation Oncology, Tianjin Medical University Cancer Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Radiation Oncology, Tianjin Medical University Cancer Hospital" #1 collaborator was "Jiangsu HengRui Medicine Co., Ltd." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Department of Radiation Oncology, Tianjin Medical University Cancer Hospital" are "Esophageal Cancer" (3 trials), "Small Cell Lung Cancer" (1 trials), "Stage II Esophageal Cancer" (1 trials), "Stage III Esophageal Cancer" (1 trials) and "Unresectable Esophageal Cancer" (1 trials). Many other conditions were trialed in "Department of Radiation Oncology, Tianjin Medical University Cancer Hospital" in a lesser frequency.

Most popular intervention types in "Department of Radiation Oncology, Tianjin Medical University Cancer Hospital" are "Drug" (3 trials), "Radiation" (3 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Definitive Radiochemotherapy" (2 trials), "SHR-1210" (2 trials), "Apatinib" (1 trials), "IMRT or VMAT" (1 trials) and "Neoadjuvant Radiochemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Radiation Oncology, Tianjin Medical University Cancer Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Department of Radiation Oncology, Tianjin Medical University Cancer Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Department of Radiation Oncology, Tianjin Medical University Cancer Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Radiation Oncology, Tianjin Medical University Cancer Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".